Canadian Snowbirds Act of 2025

Senate Bill

S. 2406

119th Congress

Canadian Snowbirds Act of 2025

In Committee

Introduced:Jul 23, 2025

Primary Sponsor

Thomas Carper

D - DE

Cosponsors

1

Quick Stats

Policy Area

Health

Summary

This bill aims to increase transparency around how prescription drug plans under Medicare make decisions about their drug formularies. It requires these plans to report on any committees affiliated with the plan or its pharmacy benefit manager that have the authority to change initial recommendations about the drug formulary, as well as any actual changes made by these committees and the justifications for those changes.

Latest Action

Read twice and referred to the Committee on Finance.

Introduced7/23/2025

StatusRead twice and referred to the Committee on Finance.

ChamberSenate

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Canadian Snowbirds Act of 2025

This bill aims to increase transparency around how prescription drug plans under Medicare make decisions about their drug formularies. It requires these plans to report on any committees affiliated with the plan or its pharmacy benefit manager that have the au

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This bill aims to increase transparency around how prescription drug plans under Medicare make decisions about their drug formularies. It requires these plans to report on any committees affiliated with the plan or its pharmacy benefit manager that have the authority to change initial recommendations about the drug formulary, as well as any actual changes made by these committees and the justifications for those changes.

Bill Number: 2406
Introduced: 7/23/2025
Status: Read twice and referred to the Committee on Finance.
Policy Area: Health

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Canadian Snowbirds Act of 2025
Bill Number: 2406
Sponsor: No sponsor
Status: Read twice and referred to the Committee on Finance.
Introduced: 7/23/2025
Summary: This bill aims to increase transparency around how prescription drug plans under Medicare make decisions about their drug formularies. It requires these plans to report on any committees affiliated with the plan or its pharmacy benefit manager that have the authority to change initial recommendation

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This bill aims to increase transparency around how prescription drug plans under Medicare make decisions about their drug formularies. It requires these plans to report on any committees affiliated with the plan or its pharmacy benefit manager that have the authority to change initial recommendations about the drug formulary, as well as any actual changes made by these committees and the justifications for those changes.

Last updated: 12/30/2025

Official Summary

Congressional Research Service summary

PBM Oversight Act of 2023This bill requires prescription drug plan (PDP) sponsors under the Medicare prescription drug benefit to report certain information about the involvement of affiliated committees in decisions about formularies.Specifically, PDP sponsors that use formularies must report to the Centers for Medicare & Medicaid Services the names and descriptions of committees that are affiliated with the PDP sponsor, or a contracted pharmacy benefit manager, that are authorized to change initial recommendations of the pharmacy and therapeutic committee about formularies. PDP sponsors must also report any formulary changes that were made by an affiliated committee and provide justifications for these decisions.The Government Accountability Office must report on the use of these types of committees with respect to formularies under the Medicare prescription drug benefit, including decision-making trends.

Key Points

Main provisions of the bill

The bill requires Medicare prescription drug plans to report information about affiliated committees that can change initial recommendations on the drug formulary.
Plans must report any formulary changes made by these affiliated committees and provide justifications for the decisions.
The Government Accountability Office must report on the use of these types of committees and their decision-making trends.

How This Impacts Americans

Potential effects on citizens and communities

This bill would affect Medicare beneficiaries and the healthcare providers who prescribe drugs covered under the Medicare prescription drug benefit. Greater transparency around formulary decision-making could help patients and doctors better understand coverage for their medications.

Policy Areas

Primary Policy Area

Health

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

2406, 119th Congress (2025). "Canadian Snowbirds Act of 2025". Source: Voter's Right Platform. https://votersright.org/bills/118-s-2406

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.

Related Bills in Health

HR 3021

Empowering Patient Choice of Medical Care Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means

HR 2111

To amend the Federal Food, Drug, and Cosmetic Act to exempt the premium cigar industry from certain regulations.

Referred to the House Committee on Energy and Commerce.

HR 2884

Anti-Racism in Public Health Act of 2025

Referred to the House Committee on Energy and Commerce.

S 1406

SOAR Act of 2025

Read twice and referred to the Committee on Finance.